Swedish News Blog

Moving with MS through music

Bobbie (Barbara) J. Severson, ARNP

Bobbie (Barbara) J. Severson, ARNP
ARNP, Swedish Multiple Sclerosis Center

It is well documented that exercise is beneficial for the body and mind because it promotes strength, endurance, flexibility, range of motion, mood, and a general sense of health and well-being. All these “perks” improve function in our daily lives. Add music to the aerobics routine and the soul is uplifted. After all, music can calm or energize the spirit and often allows us to move more freely.

The MS Center at Swedish offers free aerobics classes to the MS community for the joy of movement and music. In contrast to the typical dance-like moves that might come to mind when you think of aerobics, the exercises in Aerobics for MS are designed to increase strength and mobility for functional movements part of everyday life. Most of all, they’re meant to be fun! Classes take place in a supportive and relaxed environment, and all abilities are invited.

For more information about MS aerobics classes...

Swedish Contributes to New Treatment Option for Multiple Sclerosis

Pavle Repovic, MD, PhD

 On September 12, 2012, the Food and Drug Administration (FDA) approved teriflunomide for the treatment of multiple sclerosis (MS). Teriflunomide (AUBAGIO) is a once-daily pill for the treatment of relapsing forms of MS. Led by Dr. Lily Jung Henson, the Swedish Neuroscience Institute was among several clinical sites that tested the drug. Results of the research showed that teriflunomide can lessen MS disease activity. Specifically, it behaves similarly to injectable therapies by slowing MS relapse frequency, the rate of disability and MRI activity.

The safety profile, however, is more challenging than ....

Results 99-100 of 100

More information about the Swedish newsroom

Explore the rest of the Swedish blog

Swedish has a social media policy

See who is blogging at Swedish

   Keep up with Swedish:

    Check out the Swedish blog

Find a Physician

              Subscribe to
             HealthWatch